LTRN / Lantern Pharma Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Lantern Pharma Inc.
US ˙ NasdaqCM ˙ US51654W1018

Deler fremragende 11,208,938 shares
Insideraktier5.450.608 shares
Insider ejerskab48,63 %
Total Insiders13
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
1610 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
1690 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Lantern Pharma Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Arunkumar Asaithambi 10% Owner - [10%] 883.920 883.920
Biological Mimetics Inc 10% Owner - [10%] 2.088.000 2.088.000
BIOS Fund I QP, LP 10% Owner - [10%] 329.904 144.719
Bhatia Kishor G. 17.400
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Vijay Chandru 3.200
Fletcher Aaron G.L. 10% Owner - [10%] 144.719 144.719
Green Park & Golf Ventures II, LLC 10% Owner - [10%] 131.697 131.697
D Jeffrey Keyser Director - [D] 0 0
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Kreis Leslie W. 10% Owner - [10%] 114.272 114.272
Margrave David R. 26.100
Franklyn G Prendergast 3.200
Panna Sharma 76.628
Silberstein David S. Director, 10% Owner - [D] [10%] 2.088.000 2.088.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LTRN / Lantern Pharma Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-06-11 KEYSER D JEFFREY 10.000 15,0000 10.000 15,0000 150.000 279 21.92 69.200 46,13

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LTRN / Lantern Pharma Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LTRN / Lantern Pharma Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-06-13 Kreis Leslie W. 7.206 3,0900 7.206 3,0900 22.267 287 1.1200 -14.195 -63,75
2025-06-13 Kreis Leslie W. 12.319 3,0900 12.319 3,0900 38.066
2025-06-13 Kreis Leslie W. 1.903 3,0900 1.903 3,0900 5.880
2025-06-13 Kreis Leslie W. 14.218 3,0900 14.218 3,0900 43.934
2025-06-13 Kreis Leslie W. 4.354 3,0900 4.354 3,0900 13.454
2025-06-12 Kreis Leslie W. 10.925 3,3800 10.925 3,3800 36.926
2025-06-12 Kreis Leslie W. 18.678 3,3800 18.678 3,3800 63.132
2025-06-12 Kreis Leslie W. 2.886 3,3800 2.886 3,3800 9.755
2025-06-12 Kreis Leslie W. 21.557 3,3800 21.557 3,3800 72.863

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LTRN / Lantern Pharma Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. by Bios Fund II, LP LTRN Common Stock S - Sale I 3,0900 -4.354 -13 114.272
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0900 -14.218 -44 373.178
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0900 -1.903 -6 49.957
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0900 -12.319 -38 323.335
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0900 -7.206 -22 189.117
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,0900 -4.354 -13 114.272
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0900 -14.218 -44 373.178
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0900 -1.903 -6 49.957
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0900 -12.319 -38 323.335
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0900 -7.206 -22 189.117
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,3800 -6.601 -22 118.626
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,3800 -21.557 -73 387.396
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,3800 -2.886 -10 51.860
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,3800 -18.678 -63 335.654
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,3800 -10.925 -37 196.323
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,4000 -103 -0 125.227
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,4000 -338 -1 408.953
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,4000 -45 -0 54.746
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4000 -293 -1 354.332
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4000 -171 -1 207.248
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,4000 -2 -0 125.330
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4000 -5 -0 409.291
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,4000 -5 -0 409.291
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,4000 -1 -0 54.791
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4000 -3 -0 207.419
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,3800 -6.601 -22 118.626
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,3800 -21.557 -73 387.396
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,3800 -2.886 -10 51.860
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,3800 -18.678 -63 335.654
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,3800 -10.925 -37 196.323
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,4000 -103 -0 125.227
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,4000 -338 -1 408.953
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,4000 -45 -0 54.746
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4000 -293 -1 354.332
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4000 -171 -1 207.248
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,4000 -2 -0 125.330
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,4000 -5 -0 409.291
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4000 -5 -0 409.291
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,4000 -1 -0 54.791
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4000 -3 -0 207.419
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,0300 -2.199 -7 125.332
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0300 -7.180 -22 409.296
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0300 -961 -3 54.792
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0300 -6.221 -19 354.630
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0300 -3.639 -11 207.422
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 2,8700 -1.632 -5 127.531
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 2,8700 -5.332 -15 416.476
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 2,8700 -714 -2 55.753
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 2,8700 -4.620 -13 360.851
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 2,8700 -2.702 -8 211.061
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,0500 -2.290 -7 129.163
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0500 -7.478 -23 421.808
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0500 -1.000 -3 56.467
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0500 -6.479 -20 365.471
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0500 -3.790 -12 213.763
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,0300 -2.199 -7 125.332
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0300 -7.180 -22 409.296
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0300 -961 -3 54.792
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0300 -6.221 -19 354.630
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0300 -3.639 -11 207.422
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 2,8700 -1.632 -5 127.531
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 2,8700 -5.332 -15 416.476
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 2,8700 -714 -2 55.753
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 2,8700 -4.620 -13 360.851
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 2,8700 -2.702 -8 211.061
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3,0500 -2.290 -7 129.163
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3,0500 -7.478 -23 421.808
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3,0500 -1.000 -3 56.467
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,0500 -6.479 -20 365.471
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,0500 -3.790 -12 213.763
2024-07-26 2024-07-24 4 KEYSER D JEFFREY LTRN Common stock X - Other D 3,1300 3.832 12 0
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 6,3300 -4.253 -27 131.453
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6,3300 -13.888 -88 429.286
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6,3300 -1.859 -12 57.467
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 6,2500 -2.126 -13 135.706
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6,2500 -6.944 -43 443.174
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6,2500 -930 -6 59.326
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 6,3300 -4.253 -27 131.453
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6,3300 -13.888 -88 429.286
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6,3300 -1.859 -12 57.467
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 6,2500 -2.126 -13 135.706
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6,2500 -6.944 -43 443.174
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6,2500 -930 -6 59.326
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,8700 -4.185 -20 137.832
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,8700 -13.686 -67 450.118
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,8700 -1.832 -9 60.256
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,8500 -15.780 -77 142.017
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,8500 -51.608 -250 463.804
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,8500 -6.909 -34 62.088
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,4000 -10.620 -47 157.797
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,4000 -34.731 -153 515.412
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,4000 -4.649 -20 68.997
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,8700 -4.185 -20 137.832
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,8700 -13.686 -67 450.118
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,8700 -1.832 -9 60.256
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,8500 -15.780 -77 142.017
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,8500 -51.608 -250 463.804
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,8500 -6.909 -34 62.088
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,4000 -10.620 -47 157.797
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,4000 -34.731 -153 515.412
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,4000 -4.649 -20 68.997
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,2000 -12.521 -53 168.417
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock X - Other I 3,1300 16.801 53 180.938
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,2000 -40.893 -172 550.143
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock X - Other I 3,1300 54.873 172 591.036
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,2000 -5.475 -23 73.646
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock X - Other I 3,1300 7.347 23 79.121
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,2000 -12.521 -53 168.417
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock X - Other I 3,1300 16.801 53 180.938
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,2000 -40.893 -172 550.143
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock X - Other I 3,1300 54.873 172 591.036
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,2000 -5.475 -23 73.646
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock X - Other I 3,1300 7.347 23 79.121
2023-12-01 2023-11-29 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4400 -91.708 -315 371.950
2023-12-01 2023-11-29 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4400 -53.640 -185 217.553
2023-12-01 2023-11-29 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3,4400 -91.708 -315 371.950
2023-12-01 2023-11-29 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3,4400 -53.640 -185 217.553
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,4000 -40.586 -179 164.137
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,4000 -132.575 -583 536.163
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,4000 -17.748 -78 71.774
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 4,4000 -100.380 -442 463.658
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 4,4000 -58.711 -258 271.193
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4,4000 -40.586 -179 164.137
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4,4000 -132.575 -583 536.163
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4,4000 -17.748 -78 71.774
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 4,4000 -100.380 -442 463.658
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 4,4000 -58.711 -258 271.193
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock S - Sale I 5,2000 -1.275 -7 26.093
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock X - Other I 1,0300 6.438 7 27.328
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock S - Sale I 5,2000 -5.170 -27 20.930
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock X - Other I 1,0300 26.100 27 26.100
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock S - Sale I 5,2000 -1.275 -7 26.093
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock X - Other I 1,0300 6.438 7 27.328
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock S - Sale I 5,2000 -5.170 -27 20.930
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock X - Other I 1,0300 26.100 27 26.100
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I QP, LP LTRN Series A Warrants X - Other I -35.347 0
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I, LP LTRN Series A Warrants X - Other I -60.432 0
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I QP, LP LTRN Common Stock X - Other I 110.636,1100 35.347 3.910.655 329.904
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I, LP LTRN Common Stock X - Other I 189.152,1600 60.432 11.430.843 564.038
2021-11-08 2021-11-04 4 Kreis Leslie W. By BP Directors, LP LTRN Stock Option A - Award I 10,32 3.200 3.200
2021-11-08 2021-11-04 4 Silberstein David S. LTRN Stock Option (Right to Buy) A - Award D 10,32 3.200 3.200
2021-11-08 2021-11-04 4 Chandru Vijay LTRN Stock Option (Right to Buy) A - Award D 10,32 3.200 3.200
2021-11-08 2021-11-04 4 PRENDERGAST FRANKLYN G LTRN Stock Option (Right to Buy) A - Award D 10,32 3.200 3.200
2021-11-08 2021-11-04 4 KEYSER D JEFFREY LTRN Stock Option (Right to Buy) A - Award D 10,32 3.200 3.200
2021-11-02 2021-10-29 4 Margrave David R. LTRN Stock Option (Right to Buy) A - Award D 10,21 26.100 26.100
2021-11-02 2021-10-29 4 Bhatia Kishor G. LTRN Stock Option (Right to Buy) A - Award D 10,21 17.400 17.400
2020-06-17 2020-06-16 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -75.688 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -168.164 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -23.871 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 131.697 131.697
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 292.605 292.605
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 41.535 211.291
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By affiliate LTRN Stock Options J - Other I 15,00 9.135 9.135
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Series A Preferred Stock C - Conversion I -35.181 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Series A Preferred Stock C - Conversion I -262.806 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Series A Preferred Stock C - Conversion I -80.454 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Series A Preferred Stock C - Conversion I -169.286 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Series A Preferred Stock C - Conversion I -289.429 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock C - Conversion I 61.214 89.522
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock C - Conversion I 457.282 668.738
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock C - Conversion I 139.989 204.723
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock C - Conversion I 294.557 294.557
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock C - Conversion I 503.606 503.606
2020-06-16 2020-06-15 4 Kreis Leslie W. LTRN Stock Options A - Award D 15,00 9.135 9.135
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Series A Preferred Stock C - Conversion I -35.181 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Series A Preferred Stock C - Conversion I -262.806 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II, LP LTRN Series A Preferred Stock C - Conversion I -80.454 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Series A Preferred Stock C - Conversion I -169.286 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I, LP LTRN Series A Preferred Stock C - Conversion I -289.429 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock C - Conversion I 61.214 89.522
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock C - Conversion I 457.282 668.738
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock C - Conversion I 139.989 204.723
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock C - Conversion I 294.557 294.557
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock C - Conversion I 503.606 503.606
2020-06-15 2020-06-15 4 PRENDERGAST FRANKLYN G LTRN Stock Option A - Award D 15,00 9.135 9.135
2020-06-15 2020-06-15 4 Bhatia Kishor G. LTRN Stock Option A - Award D 15,00 52.200 52.200
2020-06-15 2020-06-15 4 SHARMA PANNA LTRN Stock Option A - Award D 15,00 76.628 76.628
2020-06-15 2020-06-15 4 Chandru Vijay LTRN Stock Option A - Award D 15,00 9.135 9.135
2020-06-15 2020-06-15 4 Margrave David R. LTRN Stock Option A - Award D 15,00 78.300 78.300
2020-06-15 2020-06-15 4 Silberstein David S. LTRN Stock Option A - Award D 15,00 9.135 9.135
2020-06-15 2020-06-11 4 KEYSER D JEFFREY LTRN Common Stock P - Purchase D 15,0000 10.000 150 10.000
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Stock Option A - Award D 15,00 9.135 9.135
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Series A Preferred Stock C - Conversion D -18.349 0
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Common Stock C - Conversion D 31.927 41.927
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883.920
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883.920
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883.920
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2.088.000
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2.088.000
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2.088.000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2.088.000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2.088.000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2.088.000
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339.512
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332.806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515.954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369.232
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista